Syra Health Corp. (SYRA)
OTCMKTS · Delayed Price · Currency is USD
0.8000
0.00 (0.00%)
At close: Aug 28, 2026

Syra Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8.097.237.985.525.621.41
Revenue Growth
0.32%-9.47%44.73%-1.83%298.43%-
Gross Profit
3.182.491.651.411.030.43
Operating Income
0.07-0.9-3.76-2.89-2.09-0
Net Income
0.13-0.9-3.76-2.94-2.12-0
Earnings Per Share
0.01-0.08-0.50-0.21-0.18-0.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.121.612.43.2800.1
Total Debt
0.150.140.450.250.930.34
Net Cash (Debt)
1.971.471.943.03-0.93-0.24
Net Cash Growth
-10.13%-24.31%-35.91%---
Net Cash Per Share
0.160.120.260.22-0.08-0.02

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.11-0.45-2.93-2.76-2.24-0.09
Capital Expenditures
-0-0-0.01-0.02-0.12-0.01
Free Cash Flow
0.11-0.45-2.94-2.77-2.37-0.09
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.35%34.43%20.71%25.60%18.35%30.52%
Operating Margin
0.92%-12.52%-47.17%-52.36%-37.20%-0.23%
Pretax Margin
1.62%-12.40%-47.10%-53.28%-37.71%-0.23%
Profit Margin
1.62%-12.40%-47.10%-53.28%-37.70%-0.23%
FCF Margin
1.35%-6.20%-36.87%-50.30%-42.10%-6.70%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.710.210.892.56--